We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+2.72%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$83B
AUM Growth
-$1.12B
Cap. Flow
-$1.51B
Cap. Flow %
-1.82%
Top 10 Hldgs %
52.4%
Holding
780
New
68
Increased
230
Reduced
336
Closed
85

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$103M
2
QCOM icon
Qualcomm
QCOM
+$87.9M
3
CVLT icon
Commault Systems
CVLT
+$87.6M
4
HLNE icon
Hamilton Lane
HLNE
+$68.2M
5
VRNS icon
Varonis Systems
VRNS
+$65.5M

Sector Composition

Rank Sector Weight
1 Technology 28.03%
2 Communication Services 19.79%
3 Consumer Discretionary 16.96%
4 Healthcare 11.82%
5 Industrials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDNT icon
101
RadNet
RDNT
$6.06B
$53M 0.06%
743,472
-34,737
-4% -$2.68M
OSIS icon
102
OSI Systems
OSIS
$3.82B
$52.9M 0.06%
207,446
-9,760
-4% -$2.55M
PATK icon
103
Patrick Industries
PATK
$2.79B
$52.9M 0.06%
487,791
-22,778
-4% -$2.39M
MGY icon
104
Magnolia Oil & Gas
MGY
$6.25B
$50.7M 0.06%
2,317,768
-187,368
-7% -$4.26M
GKOS icon
105
Glaukos
GKOS
$11B
$50.6M 0.06%
447,805
+376
+0.1% +$35.9K
PIPR icon
106
Piper Sandler
PIPR
$5.34B
$49.4M 0.06%
581,108
-27,148
-4% -$2.29M
HURN icon
107
Huron Consulting
HURN
$2.39B
$48.7M 0.06%
281,925
-13,171
-4% -$2.16M
ABEV icon
108
Ambev
ABEV
$43.5B
$47.7M 0.06%
19,300,817
-170,581
-0.9% -$406K
CRSP icon
109
CRISPR Therapeutics
CRSP
$5.22B
$47.2M 0.06%
899,331
-10,383
-1% -$622K
AGYS icon
110
Agilysys
AGYS
$3.03B
$46.4M 0.06%
390,595
+22,241
+6% +$2.68M
VRDN icon
111
Viridian Therapeutics
VRDN
$2.59B
$46.1M 0.06%
1,481,135
-69,193
-4% -$1.9M
SF
112
Stifel
SF
$12.8B
$46.1M 0.06%
551,706
+297,544
+117% +$23.8M
FROG icon
113
JFrog
FROG
$10.4B
$44.5M 0.05%
712,765
+107,258
+18% +$6.1M
ALHC icon
114
Alignment Healthcare
ALHC
$2.8B
$44.2M 0.05%
+2,236,058
New +$40.2M
OII icon
115
Oceaneering
OII
$5.08B
$44M 0.05%
1,831,434
-65,603
-3% -$1.58M
KTOS icon
116
Kratos Defense & Security Solutions
KTOS
$12B
$44M 0.05%
579,186
-233,271
-29% -$19.1M
VSEC icon
117
VSE Corp
VSEC
$6.81B
$43.9M 0.05%
254,036
+20,156
+9% +$3.45M
OSW icon
118
OneSpaWorld
OSW
$2.7B
$43.5M 0.05%
2,096,268
-97,933
-4% -$2.05M
BMRN icon
119
BioMarin Pharmaceuticals
BMRN
$13.6B
$42.3M 0.05%
711,771
-1,236
-0.2% -$67.3K
CALX icon
120
Calix
CALX
$2.51B
$41.8M 0.05%
789,892
+172,879
+28% +$10.1M
WHD icon
121
Cactus
WHD
$5.8B
$41.8M 0.05%
914,091
-42,708
-4% -$1.79M
PCOR icon
122
Procore
PCOR
$8.81B
$41.6M 0.05%
572,027
-26,723
-4% -$1.98M
SITE icon
123
SiteOne Landscape Supply
SITE
$4.22B
$41.5M 0.05%
333,417
-27,153
-8% -$3.44M
EXTR icon
124
Extreme Networks
EXTR
$3.2B
$41.4M 0.05%
2,488,148
+267,150
+12% +$4.91M
TXRH icon
125
Texas Roadhouse
TXRH
$14.1B
$41.2M 0.05%
248,340
-25,561
-9% -$4.33M

Similar funds

Loomis, Sayles & Company's Q4 2025 Portfolio in Review

As of Q4 2025, Loomis, Sayles & Company held 780 positions worth $83B, down 1.3% from $84.1B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Loomis, Sayles & Company's Q4 2025 filing shows 68 new, 230 increased, 336 reduced and 85 closed positions. Its largest new stake was Alignment Healthcare: 2,236,058 shares worth $44.2M. The largest sale was NVIDIA, an estimated $103M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Loomis, Sayles & Company's largest Q4 2025 buy was Alignment Healthcare: 2,236,058 shares worth $44.2M.
  • Loomis, Sayles & Company added most to Progressive in Q4 2025, an estimated $104M increase.
  • Loomis, Sayles & Company's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $103M.
  • Loomis, Sayles & Company fully exited Commault Systems in Q4 2025, selling an estimated $87.6M.
  • Loomis, Sayles & Company's ten largest holdings make up 52% of its $83B portfolio in Q4 2025.
  • Loomis, Sayles & Company opened 68 new positions and closed 85 in Q4 2025.
  • Loomis, Sayles & Company's portfolio value fell 1.3% quarter-over-quarter to $83B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2025, filed 12 Feb 2026.